WhaleCreep

Whitefort Capital Management, LP 13F holdings, Q1 2025

Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →

Whitefort Capital Management, LP disclosed 15 US equity positions worth $212.5m in its Q1 2025 13F filing. The largest position was ABUS at 21.9% of the reported book, followed by ROIV and JOYY. Against the Q4 2024 filing, it opened 2 new positions, added to 3 and reduced 2 among the top 15 holdings.

← Q4 2024 · Q2 2025 →

What did Whitefort Capital Management, LP own in Q1 2025? Top 15 positions

#StockSectorWeightValueSharesΔ sharesvs Q4 2024
1 ABUS ARBUTUS BIOPHARMA CORP Healthcare 21.9%$46.4m13,307,967 0% held
2 ROIV ROIVANT SCIENCES LTD Healthcare 16.2%$34.4m3,411,000 43% added
3 JOYY JOYY INC Communication Services 15.0%$31.9m759,443 81% added
4 GNW GENWORTH FINL INC Financial Services 10.0%$21.2m2,986,960 0% held
5 LQDA LIQUIDIA CORPORATION Healthcare 7.3%$15.5m1,050,180 -47% reduced
6 OPKO HEALTH INC 7.1%$15.1m9,350,000 – new
7 CDZI CADIZ INC 5.1%$10.9m3,719,951 0% held
8 OABI OMNIAB INC 4.4%$9.4m3,914,896 – new
9 GLOBAL SHIP LEASE INC NEW 4.0%$8.4m369,768 0% held
10 INNOVATE CORP 3.3%$7.1m12,218,000 0% held
11 VATE INNOVATE CORP 2.7%$5.8m743,000 132% added
12 SABRE GLBL INC 2.3%$5.0m5,000,000 0% held
13 MAIDEN HOLDINGS LTD 0.5%$1.1m1,997,005 0% held
14 NEXTNAV INC 0.1%$208.0k47,264 -53% reduced
15 TRIB TRINITY BIOTECH PLC 0.0%$46.7k81,902 0% held

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.